NAPWA

The Global Forum for MSM and HIV has released an analysis of its 2012 Global Men’s Health and Rights Study (GMHRS) concentrating on young men under 30 who have sex with men (MSM), complementing the full report which came out in December 2012. Taken together, both reports reveal that MSM globally are faced with high levels

Come to ACON’s ENDING HIV Tour 2013 and find out how you can contribute to ending HIV.

Come to ACON's ENDING HIV Tour 2013 and find out how you can contribute to ending HIV. Ask questions, get informed, and create a movement that will stop HIV in its tracks!

 

Join in at the:

 

Show

read more

How often do you hear or see a headline like: "science close to cure for HIV" or "HIV cure around the corner"? This interview with Emeritus Professor John Dwyer from the University of New South Wales takes a look at how science is going in developing vaccines and treatments.

The Ending HIV campaign aims to open a discussion with gay men about the real possibility that HIV transmission in NSW could be virtually eliminated by 2020 as a result of advances in testing technologies and HIV treatments. 

 

Everything has changed. We can end HIV.

The Ending HIV campaign aims to open a discussion with gay men about the real possibility that HIV transmission in NSW could be virtually eliminated by 2020 as a result of advances in testing technologies and HIV treatments. 

Produced by ACON, NSW’s leading HIV and gay health organisation, the campaign focuses on three key activities needed to help end the epidemic:

Show

read more

The recent MTN-007 study concluded that a "reduced glycerin formulation of tenofovir 1% gel was safe and well tolerated rectally and should be advanced to Phase 2 development."

The US National Institute of Allergy and Infectious Diseases (NIAID) has announced that it is discontinuing the HVTN 505 HIV vaccine trial. This trial, which started in July 2009, has involved 2504 gay and transgender volunteers in 19 US cities. Since the successful conclusion of the RV144 vaccine trial in September 2009, HVTN 505, as

A major international research study involving Murdoch University has found that individuals born with high numbers of a receptor known as HLA-C on their cells can naturally inhibit HIV.

University of Minnesota physicians are set to perform Tuesday a groundbreaking transplant to cure a patient of HIV/AIDS and acute lymphoblastic leukemia (ALL).

ASHM's inaugural Clinical Lecture Series 'Treatment as Prevention?' held in Sydney, Brisbane and Melbourne late March was hailed a success. The keynote presentation was delivered by international speaker Dr Kenneth Mayer, M.D. Professor of Medicine at Harvard, and Director of Research at the Fenway Institute and the Beth Israel Deaconess Medical Center. Video from the talk is now available.

Addressing a topic that has received remarkably little research attention over the years, Dr Vivian Hope of Public Health England told the British HIV Association conference yesterday that injection of image- and performance-enhancing drugs is rising in England and Wales. Moreover, his research suggests that men may be acquiring bloodborne viruses through this route

Researchers analyzed studies from 15 countries over about a decade.

Taking HIV pre-exposure prophylaxis (PrEP) does not lead to increased levels of sexual risk behaviour among gay men, investigators from the United States report in the online edition of the Journal of Acquired Immune Deficiency Syndromes. Numbers of sexual partners fell, as did the proportion of men reporting unprotected anal sex. “We found no

Well, looks like they won’t be going the way of VHS tapes and cassettes (ask your parents) just yet,because researchers have just figured out a way to turn them into affordable, blood-analysing, cellular-imaging, laser-scanning microscopes capable of completing HIV tests in mere minutes.

Increasing HIV testing frequency, and giving everyone antiretroviral therapy (ART), would not in themselves reduce HIV prevalence in US gay men, a mathematical model suggests. These measures would produce, in the model’s baseline scenario, a 34% reduction in the cumulative number of new infections and a 19% reduction in cumulative deaths by the year 2023.

The female genital tract appears to be a 'reservoir' for ongoing HIV replication, even during effective antiretroviral therapy, an international team of investigators report in Clinical Infectious Diseases. “The female genital tract may serve as a reservoir of persistent HIV-1 replication during cART [combination antiretroviral therapy] and affect the use of cART to

Reduction of services at the Biala sexual health clinic in Brisbane will 'greatly interfere' with Queensland's ability to reduce the rates of HIV Infection, Chair of Queensland's Ministerial Advisory Committee (MAC) Dr Darren Russell told the ABC's 7.30 Report last week.

Self-testing for HIV is highly acceptable to people in a variety of settings, investigators report in the open-access journal PLoS Medicine. The authors reviewed the results of 21 separate studies and found an acceptability rate of up to 100%.

Queensland Health will begin a survey this weekend to help gauge the best way to reduce HIV infections in the state.

Self-testing for HIV is highly acceptable to people in a variety of settings, investigators report in the open-access journal PLoS Medicine. The authors reviewed the results of 21 separate studies and found an acceptability rate of up to 100%. Self-testing using point-of-care assays generally provided accurate results, and there was no evidence that a positive

A new study by Los Alamos National Laboratory and University of Pennsylvania scientists defines previously unknown properties of transmitted HIV-1.